Recent Updates
Recently added Catalysts
KURA Positive Sentiment Score: 75/100

Kura Oncology to Participate in Three Upcoming Investor Conferences

Thursday, February 22, 2024 1 min read
Key Takeaway: Kura Oncology, a biopharmaceutical company focused on precision cancer treatments, announced its participation in three upcoming investor conferences. CEO Troy Wilson will partake in various discussions, including a fireside chat at the TD Cowen Health Care conference and a corporate panel on leukemia. These events are scheduled for March 4, March 12, and March 14, 2024. Kura will also provide live audio webcasts, ensuring investors have access to these discussions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kura Oncology is actively engaging with investors, highlighting its transparency.
  • Participation in multiple high-profile conferences indicates confidence in its initiatives.
  • Live webcasts will increase accessibility and engagement with stakeholders.

Full Press Release Details

SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in three upcoming investor conferences:
A fireside chat at the TD Cowen Health Care conference in Boston at 9:10 a.m. ET / 6:10 a.m. PT and participation in the Leukemia Corporate Panel at 12:50 p.m. ET / 9:50 a.m. PT on March 4, 2024;
A fireside chat at the Leerink Partners Global Biopharma Conference in Miami at 11:20 a.m. ET / 8:20 a.m. PT on March 12, 2024; and
A fireside chat at the Barclays Global Healthcare Conference in Miami at 9:00 a.m. ET / 6:00 a.m. PT on March 14, 2024.
Live audio webcasts will be available in the Investors section of Kura’s website at www.kuraoncology.com, with archived replays available following all three events.
Executive Vice President, Investor Relations &
Corporate Communications
pete@kuraoncology.com
Alexandra Weingarten
Associate Director, Corporate Communications &
alexandra@kuraoncology.com

Tags

Frequently Asked Questions

Who is participating in the investor conferences?

Troy Wilson, Ph.D., J.D., is participating in the conferences.

When is the TD Cowen Health Care conference?

The TD Cowen Health Care conference is on March 4, 2024.

Where can I find the conference webcasts?

Live webcasts will be available on Kura's website in the Investors section.

What is Kura Oncology focused on?

Kura Oncology focuses on precision medicines for cancer treatment.

When will archived replays of the events be available?

Archived replays will be available after all three events.

Tags: KURA Viatris Investor Conferences Healthcare investor conferences cancer treatment precision medicines Troy Wilson
Last updated: Feb 22, 2024